Abstract:OBJECTIVE:To explore biological effects of up-regulated expression of transfected FOLR1 gene on SKOV3 cell lines following action by cisplatin (DDP) . METHODS:Three groups of cells originated from the same SKOV3 cell line were used in this research, including the SKOV3 cell line(blank control), the cell line transfected with lentiviral pWPI plasmid(no-load control) and the cell line transfected with FOLR1 gene via lentiviral pWPI plasmid(experimental group). Next, the mRNA and protein expression of FOLR1 gene in the three groups were detected by reverse transcription (RT) -PCR and western blot, respectively. Methyl thiazolyl tetrazolium (MTT) assay was used to analysis cells growth curve and identify their sensitivity to cisplatin, and their half inhibition concentration(IC50) values were calculated. Based on the IC50 value(3.6 µg/ml) in the experimental group, different levels of cisplatin concentration (0.5×IC50, 1×IC50, 2×IC50, respectively) were administered to the three groups of cells, and the inhibition rates, apoptosis rates as well as apoptosis proportion of each group after 24, 48, 72 hours were further recorded.Finally, the residual cisplatin concentrations in the three group cells acted successively by 1×IC50 cisplatin for 48 hours were measured by high performance liquid chromatography (HPLC) . P value less than 0.05 were defined as statistically significant. RESULTS:RT-PCR and western blot detection showed that stable mRNA and protein expression of the FOLR1 gene in the experimental group while the other two groups were not. MTT assay demonstrated that higher cell growth rate, sensitivity to cisplatin(IC50 = 3.6 µg/ml) and inhibition rate in the experimental group compared with those in the other two groups (P < 0.05) , which showed no significance in intergroup comparison(P > 0.05). Flow cytometry showed apoptosis rates among three groups increased with higher cisplatin concentrations and longer action duration in dosage-time dependent manner (P < 0.05) , and the proportion of S phase cells increased with higher cisplatin concentration in dosage-dependent manner (P < 0.05) ;for the same concentration and duration, the experimental group showed significantly different apoptosis rates and S phase cells compared with the other two groups, which demonstrated no significance in intergroup comparison (P > 0.05) . After action by cisplatin(3.6 µg/ml) for 48 hours, HPLC showed significantly higher residual cisplatin concentration (2.60 ± 0.21) µg/10(6) cell counts in experimental group than those in no-load control group (1.49 ± 0.12) µg/10(6) cell counts and blank control group(1.54 ± 0.11) µg/10(6) cell counts, respectively (P < 0.05) , and the comparison within the latter two groups showed no significance (P > 0.05). CONCLUSION:Up-regulated expression of the transfected FOLR1 gene in SKOV3 cells may be associated with higher sensitivity to cisplatin, residual cisplatin concentration and higher proportion of S phase cells, and tended to inhibit cancer cells growth and induce apoptosis.

Expression and influence of ING5 on cisplatin sensitivity in different ovarian cancer cells

GANT61 Elevates Chemosensitivity to Cisplatin Through Regulating the Hedgehog, AMPK and Camp Pathways in Ovarian Cancer

Study on Expression of ING5 in Liver Cancer

ING5 suppresses breast cancer progression and is regulated by miR-24

MiR-1307 Promotes Ovarian Cancer Cell Chemoresistance by Targeting the ING5 Expression

Small Molecules Identified from a Quantitative Drug Combinational Screen Resensitize Cisplatin's Response in Drug-Resistant Ovarian Cancer Cells

The roles of ING5 in cancer: A tumor suppressor

OSI-906 Restores the Sensitivity of Ovarian Clear Cell Carcinoma to Cisplatin by Targeting the IGF1R/AKT Pathway

Effects of Cisplatin on the Expression of Several Growth and Apoptosis Related Genes in Ovarian Cancer Cells

Down-regulation of Ras-related Protein Rab 5C-Dependent Endocytosis and Glycolysis in Cisplatin-resistant Ovarian Cancer Cell Lines

OIP5 Promotes Growth, Metastasis and Chemoresistance to Cisplatin in Bladder Cancer Cells

Downregulation of Vimentin Expression Increased Drug Resistance in Ovarian Cancer Cells

ING5 Inhibits Migration and Invasion of Esophageal Cancer Cells by Downregulating the IL-6/CXCL12 Signaling Pathway

Research on Ginkgolide B increases Cisplatin sensitivity in ovarian cancer cell via down-regulation of excision repair cross-complementing 1(ERCC1) in vitro

ING5 overexpression upregulates miR-34c-5p/Snail1 to inhibit EMT and invasion of lung cancer cells

Cisplatin on the Effect of Aquaporin 5 Protein Expression of SKOV3 and Its Regulation

[Biological Effects of Upregulated Expression of Transfected FOLR1 Gene on SKOV3 Cell Lines Acted by Cisplatin].

The proliferation suppression effect of ginsenoside Rg3 combined with cisplatin on human high-metastasis ovarian cancer cell line H0-8910PM in vitro

Activation of hedgehog signaling and its association with cisplatin resistance in ovarian epithelial tumors.

Induction of Autophagy Contributes to Cisplatin Resistance in Human Ovarian Cancer Cells

Effect of oxaliplatin on the growth of tumor and angiopoietin-2 in mice models of endometrial carcinoma